Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples

J Clin Microbiol. 1995 Mar;33(3):738-41. doi: 10.1128/jcm.33.3.738-741.1995.

Abstract

A rapid screening assay for the detection of resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples was developed by using single doses of both drugs and an immediate-early antigen plaque reduction assay. Results of the rapid assay with peripheral blood leukocytes as the viral inoculum were compared with those of a conventional assay with cell-free virus from the relevant viral isolates. Both assays gave overlapping results. The rapid assay offers the following major advantages: (i) it provides results within 4 to 6 days, (ii) it can be performed with peripheral blood leukocytes, and (iii) it reliably detects drug-resistant human cytomegalovirus strains.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral / blood
  • Blood / virology
  • Cytomegalovirus / drug effects*
  • Cytomegalovirus / immunology
  • Cytomegalovirus / isolation & purification
  • Cytomegalovirus Infections / diagnosis
  • Cytomegalovirus Infections / virology*
  • Drug Resistance, Microbial
  • Foscarnet / pharmacology*
  • Ganciclovir / pharmacology*
  • Humans
  • Viral Plaque Assay / methods*

Substances

  • Antigens, Viral
  • Foscarnet
  • Ganciclovir